Brain iron chelation may act as a general disease-nonspecific mechanism that engages multiple pathways, including downstream effectors of HIF-1α and insulin signaling, to intersect with and possibly slow the progression of multiple human neurological diseases including AD, PD, ischemic stroke, and ICH. This evidence concerns the gene HIF1A and ischemic stroke.